Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CarMax, Inc (KMX) vs Nuwellis Inc (NUWE) Price & Performance

CarMax, IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

CarMax, Inc vs Nuwellis Inc — how do they compare? CarMax, Inc trades at $55.91 (market cap $7.93B), while Nuwellis Inc trades at $2.95 (market cap $1.09M). The key difference: CarMax, Inc is far larger — about 7275.2× Nuwellis Inc's market cap, and CarMax, Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

KMXNUWE
Market Cap
$7.93B$1.09M
Sector
Consumer CyclicalTechnology
52-Week High
$63.53$527.46
52-Week Low
$30.88$2.80
Enterprise Value
$26.44B-$722.58K

Returns comparison

Trailing returns across standard periods

About CarMax, Inc

CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.

Read more on KMX

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE